157 related articles for article (PubMed ID: 16338585)
1. Chlamydia trachomatis persistence: an update.
Mpiga P; Ravaoarinoro M
Microbiol Res; 2006; 161(1):9-19. PubMed ID: 16338585
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.
Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV
Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874
[TBL] [Abstract][Full Text] [Related]
3. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia trachomatis: the Persistent Pathogen.
Witkin SS; Minis E; Athanasiou A; Leizer J; Linhares IM
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28835360
[No Abstract] [Full Text] [Related]
5. Considerations on Chlamydia trachomatis disease expression.
Brunham RC; Rekart ML
FEMS Immunol Med Microbiol; 2009 Mar; 55(2):162-6. PubMed ID: 19159424
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
7. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression.
Gérard HC; Branigan PJ; Schumacher HR; Hudson AP
J Rheumatol; 1998 Apr; 25(4):734-42. PubMed ID: 9558178
[TBL] [Abstract][Full Text] [Related]
8. Chlamydial genovar distribution after community wide antibiotic treatment.
Bain DL; Lietman T; Rasmussen S; Kalman S; Fan J; Lammel C; Zhang JZ; Dawson CR; Schachter J; Stephens RS
J Infect Dis; 2001 Dec; 184(12):1581-8. PubMed ID: 11740734
[TBL] [Abstract][Full Text] [Related]
9. Analysis of modulated gene expression in a model of Interferon-gamma-induced persistence of Chlamydia trachomatis in HEp-2 cells.
Kokab A; Jennings R; Eley A; Pacey AA; Cross NA
Microb Pathog; 2010 Nov; 49(5):217-25. PubMed ID: 20558272
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis infections: progress and problems.
Stamm WE
J Infect Dis; 1999 Mar; 179 Suppl 2():S380-3. PubMed ID: 10081511
[TBL] [Abstract][Full Text] [Related]
11. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.
Morrison RP
Semin Immunol; 1991 Jan; 3(1):25-33. PubMed ID: 1680011
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis, a hidden epidemic: effects on female reproduction and options for treatment.
Carey AJ; Beagley KW
Am J Reprod Immunol; 2010 Jun; 63(6):576-86. PubMed ID: 20192953
[TBL] [Abstract][Full Text] [Related]
13. The immunology of Chlamydia trachomatis.
Zdrodowska-Stefanow B; Ostaszewska-Puchalska I; Puciło K
Arch Immunol Ther Exp (Warsz); 2003; 51(5):289-94. PubMed ID: 14626428
[TBL] [Abstract][Full Text] [Related]
14. New approaches to the diagnosis, treatment, and prevention of chlamydial infection.
Marrazzo JM; Stamm WE
Curr Clin Top Infect Dis; 1998; 18():37-59. PubMed ID: 9779350
[No Abstract] [Full Text] [Related]
15. [Chlamydia trachomatis urogenital infections in women. Best diagnostic approaches].
Hamdad F; Orfila J; Boulanger JC; Eb F
Gynecol Obstet Fertil; 2004 Dec; 32(12):1064-74. PubMed ID: 15589784
[TBL] [Abstract][Full Text] [Related]
16. The molecular biology and diagnostics of Chlamydia trachomatis.
Birkelund S
Dan Med Bull; 1992 Aug; 39(4):304-20. PubMed ID: 1526183
[TBL] [Abstract][Full Text] [Related]
17. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
[TBL] [Abstract][Full Text] [Related]
18. Host defense peptides: general overview and an update on their activity against Chlamydia spp.
Di Francesco A; Favaroni A; Donati M
Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1215-24. PubMed ID: 24111488
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
[TBL] [Abstract][Full Text] [Related]
20. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping.
Dean D; Suchland RJ; Stamm WE
J Infect Dis; 2000 Sep; 182(3):909-16. PubMed ID: 10950788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
